Chengdu Kanghong Pharmaceutical Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chengdu Kanghong Pharmaceutical Group Co Ltd with three other
companies in this sector in CHINA :
Anhui Fengyuan Pharmaceutical
sales of 3.24 billion Chinese Renmimbi [US$463.85 million]
of which 51%
was Medicine Manufacturing),
Heilongjiang ZBD Pharmaceutical Co Ltd
(3.29 billion Chinese Renmimbi [US$471.55 million]
of which 62%
was Pharmaceutical Industry), and
Jiuzhitang Company Limited
(3.18 billion Chinese Renmimbi [US$456.06 million]
of which 88%
was Pharmacuetical Industry).
During the year ended December of 2019, sales at
Chengdu Kanghong Pharmaceutical Group Co Ltd were 3.26 billion Chinese Renmimbi (US$466.59 million).
increase of 11.6%
versus 2018, when the company's sales were 2.92 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chengdu Kanghong Pharmaceutical Group Co Ltd
(and since 2014, sales have increased a total of 95%).
Sales of Pharmaceutical Manufacturing saw an increase
11.7% in 2019, from
2.92 billion Chinese Renmimbi to 3.26 billion Chinese Renmimbi.
Not all segments of Chengdu Kanghong Pharmaceutical Group Co Ltd experienced an increase in sales in 2019:
sales of Others fell 3.7% to 943,256.44 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).